Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe thigh is one of three licensed injection sites for Mounjaro (tirzepatide), and for many people it becomes their preferred spot. You can inject Mounjaro in the thigh yourself without needing anyone to help, making it a practical choice for weekly doses at home. Mounjaro is a prescription-only medicine; a qualified prescriber assesses whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture your outer thigh as a rough rectangle: start a hand's width above your knee and stop a hand's width below where your hip creases when you sit. The outer, slightly flatter face of the thigh is the target, not the inner thigh, not the back. That zone tends to have enough subcutaneous fat to take the needle comfortably, regardless of body composition, and it is far enough from major blood vessels and nerves that the risk of hitting them is very low.
Within that rectangle, aim for a fresh spot each time. Move at least a couple of centimetres from last week's site. Some people work their way around the thigh in a rough clockwise pattern, which takes the guesswork out of it. You can use both thighs in rotation, alternating left and right each week gives each site a full fortnight to recover before it is used again.
Sitting down with your thigh muscle relaxed makes the injection easier. Pinching the skin gently before pressing the pen in is a habit worth building, especially if you are on an earlier, lower dose and have less subcutaneous tissue available. The Mounjaro overview page covers how the KwikPen itself works if you want a refresher before your first injection.
Some people find the thigh stings slightly more than the abdomen, particularly in the first few weeks. This is not a sign anything has gone wrong. The subcutaneous layer in the thigh can be thinner in some individuals, and any tiny movement of the leg mid-injection (which is easy to do without realising) can intensify the sensation briefly.
Letting the pen warm to room temperature for about ten minutes before injecting is one of the simplest ways to reduce that sting. Cold medicine straight from the fridge is one of the most common reasons people report discomfort. A quick check before you inject: hold the pen between your palms for a moment; if it still feels cold, wait a little longer.
Post-injection, a small raised area or mild redness is normal and typically settles within 24 to 48 hours. If you notice bruising, it usually means a tiny capillary was nicked, nothing serious, but worth noting so you can avoid the same precise spot next week. Information on specific technique for thigh injections goes into more detail on angle and skin-pinching method.
Site rotation is not optional housekeeping, it matters clinically. Injecting the same small patch of skin repeatedly can cause lipodystrophy, a hardening or thinning of the subcutaneous tissue that slows medicine absorption. With a weekly injection schedule, the thigh-only approach is entirely workable as long as you are genuinely moving the spot each time. You can also rotate between the thigh, abdomen and upper arm across different weeks if one area is consistently more comfortable.
Certain things at the injection site should prompt you to contact your prescriber or care team: a lump that grows rather than shrinks over several days, skin that looks infected (warmth, spreading redness, pus), or pain that is out of proportion to a normal sting. Systemic symptoms (fever, severe abdominal pain that radiates to the back) are unrelated to the injection site itself and need urgent medical assessment; the NHS patient information page for tirzepatide on the NHS website lists symptoms that require prompt medical attention. The page on abdominal symptoms and Mounjaro has more on distinguishing injection-site discomfort from signs that need clinical review.
If you are injecting Mounjaro in the thigh and find your leg feels unusually sore or the site is not recovering between doses, raise it with your prescriber at the next review. There is no clinical need to push through persistent site problems when two other licensed sites are available.
Injection-site choice is just one small part of getting the most from tirzepatide. Mounjaro is a dual GIP and GLP-1 receptor agonist licensed for weight management in adults, how you inject it matters far less than consistent weekly dosing, the lifestyle changes your prescriber discusses with you, and staying in contact with your clinical team when anything feels off. Some early questions (for example, whether existing medicines interact with your treatment) are worth raising before you begin; the page on Mounjaro and blood pressure medication is a useful read if that applies to you.
On the question of increased thirst during treatment, that is a topic our prescribers hear about regularly, it is worth understanding before your first few weeks so it does not catch you off guard. And if you are thinking about where private treatment fits into your plans, the Mounjaro cost page explains what a legitimate private prescription actually includes.
Mounjaro is a prescription-only medicine, and the right injection site for you is confirmed as part of your clinical assessment. If you would like to explore whether treatment is suitable, you can start your free consultation with our prescribers, reviewed the same day, no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.